EPM
EPM
Industry:
Manufacturing Plastics And Rubber Manufacturing Supply Chain Management
Founded:
2003-01-01
Address:
Smålandsstenar, Jonkopings Lan, Sweden
Country:
Sweden
Website Url:
http://www.epmab.com
Total Employee:
1+
Status:
Active
Contact:
46-70-6637072
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF WordPress Font Awesome Apache Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online Office 365 Mail
Similar Organizations
Arham Techplast
Arham Techplast is a manufacturer, developer and supplier of engineering plastic parts.
Pisani
Pisani is a manufacturer and supplier of plastic boxes.
Official Site Inspections
http://www.epmab.com
- Host name: ing.r101.websupport.se
- IP address: 109.235.174.4
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "EPM"
EpimAb Biotherapeutics - Crunchbase Company Profile & Funding
EpimAb Biotherapeutics is a privately owned biopharmaceutical company dedicated to generating novel bi-specific antibody therapeutics based on its proprietary FIT-Ig (Fabs-In-Tandem) …See details»
Home | EpimAb
We have a robust and sustainable pipeline with 4 clinical stage assets (EMB-01, EMB-02 , EMB-06 and EMB-09) and more than 10 preclinical stage candidates. Our proprietary FIT-Ig® …See details»
HILDEBRAND - EPMAB
Ledande inom området för extraherande av damm, elektrostatisk laddning och urladdning Våra medarbetare arbetar samarbetat och nära med dig, kompetent och flitigt genom hela projektet. …See details»
HEM - EPMAB
EPM i Smålandsstenar levererar utrustning till extruderingsindustrin för filmblåsning och cast. Vi levererar allt från kompletta linjer till komponenter såsom kylringar, kalibreringskorgar, avdrag, …See details»
EpimAb Biotherapeutics - Craft
EpimAb Biotherapeutics is dedicated to generating novel bi-specific antibody therapeutics based on its proprietary FIT-Ig (Fabs-In-Tandem) platform. With this innovative platform, EpimAb is …See details»
Chengbin Wu – CEO & Founder, EpimAb Biotherapeutics
May 12, 2024 EpimAb Biotherapeutics' Chengbin Wu explains why the expansion of bispecifics into solid tumors and autoimmune diseases marks a major therapeutic turning point. He …See details»
EpimAb Biotherapeutics and Vignette Bio enter license agreement …
Sep 4, 2024 EpimAb Biotherapeutics and Vignette Bio have entered into a license agreement for the development and commercialization of EMB-06, a BCMA × CD3 bispecific antibody, with …See details»
EpimAb|岸迈生物【官网】
岸迈生物是一家创新型国际化生物技术企业，在上海和苏州分别设有研发中心和GMP生产基地，专注于利用自主知识产权的双特异性抗体技术平台FIT-Ig®进行创新生物药的研究和开发。基 …See details»
EPM - Crunchbase Company Profile & Funding
Headquarters Regions European Union (EU), Nordic Countries, Scandinavia Founded Date Jan 1, 2003 Operating Status Active Company Type For Profit Contact Email [email protected] …See details»
EpimAb Biotherapeutics and Vignette Bio Announce Strategic ...
Sep 4, 2024 SHANGHAI and SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- EpimAb Biotherapeutics, Inc. (“EpimAb” or “EpimAb Biotherapeutics”) a clinical stage …See details»
EpimAb Biotherapeutics and Almirall Announce Bispecific …
Oct 12, 2023 SHANGHAI & BARCELONA, Spain, October 12, 2023--EpimAb Biotherapeutics, a clinical stage biopharmaceutical company specializing in the development of multispecific …See details»
DOTECO - EPMAB
Passion för plastindustrin Sedan 1994 har Doteco arbetat framgångsrikt inom plastindustrin, speciellt vid extrudering av plastfilm, profil och syntetfibrer. Genom lyhördhet för våra kunder …See details»
EpimAb Biotherapeutics Announces U.S. FDA Clearance of IND …
Jun 8, 2022 Shanghai and Suzhou, China, June 8, 2022 - EpimAb Biotherapeutics, a clinical-stage biotechnology company specializing in bispecific antibody development, today …See details»
EpimAb Biotherapeutics to Present Initial First-in-human Data of …
SHANGHAI, China, September 20, 2023--EpimAb Biotherapeutics will Present Initial First-in-Human Data of EMB-02 at the 2023 ESMO ConferenceSee details»
PipeLine | EpimAb
We have a robust and sustainable pipeline with 5 clinical stage assets (EMB-01, EMB-02 , EMB-06 , and EMB-09) and more than 10 preclinical stage candidates. Our proprietary FIT-Ig® …See details»
EpimAb Biotherapeutics and Almirall Announce Bispecific …
Shanghai/Barcelona, October 12, 2023 - EpimAb Biotherapeutics, a clinical stage biopharmaceutical company specializing in the development of multispecific antibodies, and …See details»
EMB-09 by EpimAb Biotherapeutics for Endometrial Cancer: …
Jan 20, 2025 EMB-09 is under clinical development by EpimAb Biotherapeutics and currently in Phase I for Endometrial Cancer. According to GlobalData, Phase I drugs for Endometrial …See details»
The anti-epithelial cell adhesion molecule (EpCAM) monoclonal …
EpMab-16, anti-epithelial cell adhesion molecule monoclonal antibody; FFPE, formalin-fixed paraffin-embedded; HE, hematoxylin and eosin. Kinetic analysis of the interactions of EpMab …See details»
TEMAC - EPMAB
40 år inom produktionen av slits-återvinningsmaskiner Temac, som är baserat i Lonate Pozzolo (provinsen Varese), startade i samarbete mellan experter inom det elektroniska och …See details»
Antitumor activities of a defucosylated anti‑EpCAM ... - PubMed
An anti‑EpCAM mAb, EpMab‑37 (mouse IgG 1, kappa) was previously developed by the authors, using the cell‑based immunization and screening method. In the present study, a …See details»